Tokunbo Adewumi
Family · Nashville, TNNPI 1023307998
Payments from drug & device makers
Across 363 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Novo Nordisk$922
- AbbVie$661
- Novartis$411
- Amgen$409
- AstraZeneca$370
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,41198%
- Education$1452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 61 | $1,024 |
| Novo Nordisk | 54 | $922 |
| AbbVie | 32 | $661 |
| Novartis | 21 | $411 |
| Amgen | 25 | $409 |
| AstraZeneca | 20 | $370 |
| Lilly USA, LLC | 24 | $338 |
| Boehringer Ingelheim | 13 | $302 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $220 |
| Kowa Pharmaceuticals America, Inc. | 13 | $207 |
| Pfizer | 10 | $180 |
| Astellas Pharma US Inc | 4 | $175 |
| Exact Sciences | 8 | $144 |
| Bayer | 9 | $140 |
| Sanofi-aventis U.S. LLC | 7 | $123 |
| Sumitomo Pharma America, Inc. | 7 | $112 |
| Merck | 6 | $105 |
| Azurity Pharmaceuticals, Inc. | 5 | $100 |
| Esperion Therapeutics, Inc. | 5 | $83 |
| Arbor Pharmaceuticals, Inc. | 4 | $74 |
| Ardelyx, Inc. | 3 | $73 |
| Johnson & Johnson | 4 | $68 |
| GSK | 3 | $59 |
| Nestle Healthcare Nutrition Inc. | 2 | $40 |
| Abbott | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Nevro Corp. | 1 | $21 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
| Insulet Corporation | 1 | $13 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,557 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 35 | $53,292 |
| LinzessLinaclotide | 29 | $27,255 |
| MounjaroTirzepatide | 18 | $25,693 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 34 | $23,607 |
| FarxigaDapagliflozin Propanediol | 22 | $23,538 |
| VraylarCariprazine Hcl | 15 | $21,400 |
| JardianceEmpagliflozin | 12 | $20,725 |
| KerendiaFinerenone | 11 | $17,229 |
| Repatha SureclickEvolocumab | 23 | $16,685 |
| XareltoRivaroxaban | 15 | $16,330 |
| GemtesaVibegron | 11 | $12,202 |
| OzempicSemaglutide | 13 | $12,033 |
| EdarbiAzilsartan Medoxomil | 20 | $11,026 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $10,566 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 12 | $5,371 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $922 | $65,32548 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $370 | $50,26267 claims |
| AbbVieLinzess, Vraylar | $661 | $48,65644 claims |
| Lilly USA, LLCMounjaro | $338 | $25,69318 claims |
| Boehringer IngelheimJardiance | $302 | $20,72512 claims |
| BayerKerendia | $140 | $17,22911 claims |
| Arbor Pharmaceuticals, Inc.Edarbi, Edarbyclor | $74 | $16,39732 claims |
| Johnson & JohnsonXarelto | $68 | $16,33015 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $112 | $12,20211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.
Other family in Nashville
- Tamera ThoenerNashville$254K
- Jennifer WilliamsNashville$213K
- Lori LankfordNashville$148K
- Melissa RikalNashville$144K
- Nicole DelliseNashville$67K
- Lesley BallanceNashville$63K
- Jeffrey WoodsNashville$38K
- Courtney HavillNashville$35K
- Collette UtleyNashville$28K
- Stacy BrownMt Juliet$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.